Lingamneni Anila

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$935,631.95

Insider Activity of Lingamneni Anila

According to the SEC Form 4 filings, Lingamneni Anila, being in a position of

  1. EVP, Chief Technology Officer at Haemonetics Corporation,
    оver the last 12 months, has bought 0 shares, and sold 4520 shares for $418,325,
    over all time since 2021-04-16, has bought 0 shares, and sold 10964 shares for $935,632.

The largest sale of all time was on 2024-05-06 and amounted to 2305 shares of Haemonetics Corporation for $218,975.

Biography of Lingamneni Anila

No biography is available at this moment.

2024-07-12SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
79
0.0002%
$90.00$7,1100%
2024-07-11SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
2,136
0.0045%
$90.00$192,2400%
2024-05-06SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
2,305
0.0045%
$95.00$218,975-12.54%
2023-09-11SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
2,305
0.0045%
$90.00$207,450-6.34%
2023-05-30SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
2,304
0.0045%
$83.33$191,992+2.78%
2022-05-19SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
1,384
0.0027%
$59.10$81,794+29.7%
2022-04-18SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
189
0.0004%
$56.55$10,688+35.49%
2021-05-19SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
92
0.0002%
$55.19$5,077+3.26%
2021-04-16SaleHaemonetics Corporation
HAE
EVP, Chief Technology Officer
170
0.0003%
$119.44$20,305-49.3%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.